3D Applications in Healthcare Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
3D technology is one of the fastest growing markets in the world. 3D imaging market is an offshoot of the traditional diagnostic imaging market. Healthcare industry relies increasingly on the 3D imaging market. 3D printing in healthcare is slowly picking up popularity. The companies working on 3D printing technology are new and mainly focused on research and development. Virtual reality in 3D market is still new and being mainly used to treat posttraumatic stress disorders and phobias.
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
- 3D diagnostic imaging market is more than 80% of the market in the overall 3D healthcare technology market.
- Currently the main players in 3D diagnostic imaging are GE Healthcare, Siemens, Philips, Toshiba and BARCO.
- The market is well established in all the geographies and North America has the largest market share with almost 50% market share.
- The market has two main players in the 3D printing in healthcare, Stratasys and 3D Systems.
- The 3D printing market is growing in the Asia Pacific region. China has been working a lot in the 3D printing market.
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
CHAP 1. EXECUTIVE SUMMARY
CHAP 2. MARKET DETERMINANTS
2.1. Key Drivers
2.1.1. Better choice over conventional methods
2.1.2. Customized products
2.1.3. Research and Development
2.1.4. Innovative and advanced technologies
2.1.5. FDA nod to 3D innovative technologies
2.2. Restraints
2.2.1. High cost to individual patient
2.2.2. Lower Adoption rate
2.2.3. Regulations
2.3. Opportunity
2.3.1. Increase in joint replacement surgeries
2.3.2. Medical Tourism
2.3.3. Bio printing technology
2.4. Challenges
2.4.1. Transplantation of vital organs
2.4.2. High adoption rate of 3D technology is a challenge
2.4.3. Regulations are a hindrance for 3D technology
CHAP 3. 3D TECHNOLOGY IN HEALTHCARE - APPLICATION
3.1. 3D Printing
3.2. Implants
3.2.1. Example of use of 3D printing in implant
3.2.2. Advantages of 3D printing in healthcare
3.2.3. Dental Implants
3.2.4. Bio Engineering
3.2.5. Bio medical applications of 3D printing
3.3. 3D printing technologies
3.3.1. Electron beam melting
3.3.2. Laminated object manufacturing
3.3.3. Thermal Inkjet Printing
3.3.4. Selective Laser Sintering
3.3.5. Fused Deposition Modeling (FDM)
3.3.6. Photo polymerization
3.4. Raw material used for 3D printing in healthcare
3.4.1. Bio Ink
3.4.2. Ceramic
3.4.3. Polymers
3.4.4. Acrylonitrile Butadiene Styrene (ABS)
3.4.5. Polyactic Acid (PLA)
3.4.6. Metal
3.5. 3D Imaging
3.5.1. 3D mammography
3.5.2. 3D computed tomography
3.6. Virtual Reality
3.6.1. Use of virtual reality in therapy
CHAP 4. STRATEGIES TO STAY COMPETITIVE IN THE 3D TECHNOLOGY MARKET IN HEALTHCARE
4.1. Research and development give rise to innovative technologies
4.2. Stratasys partners with Worrell for new 3D printed medical devices
4.2.1. Organovo and Johnson & Johnson enter into partnership for 3D bio printing drug discovery research
4.2.2. Organovo enters into partnership with the Yale School of Medicine for 3D bioprinted tissue project
4.3. Acquisition gives upper hand over the competitors
4.3.1. Case Study
CHAP 5. GEOGRAPHICAL ANALYSIS
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. Regulations regarding medical devices in Europe
5.2.2. Prevalent diseases in Europe
5.2.3. United Kingdom (UK)
5.2.4. France
5.2.5. Germany
5.3. Asia Pacific (APAC)
5.3.1. China
5.3.1.1. Diseases prevalence in China
5.3.2. Japan
5.3.2.1. Regulations in Japan
5.3.3. India
CHAP 6. COMPANY PROFILING
6.1. 3 D Imaging
6.1.1. GE Healthcare
6.1.1.1. Overview
6.1.1.2. Strategic Moves
6.1.1.3. SCOT Analysis
6.1.2. Siemens Healthcare
6.1.2.1. Overview
6.1.2.2. Siemens Healthcare Products Portfolio
6.1.2.3. Strategic Moves (2013-14)
6.1.2.4. SCOT Analysis
6.1.3. Philips Healthcare
6.1.3.1. Overview
6.1.3.2. Phillips Healthcare Products Portfolio
6.1.3.3. Strategic Moves (2013-14)
6.1.3.4. SCOT Analysis
6.1.4. Toshiba Medical Systems
6.1.4.1. Overview
6.1.4.2. Toshiba Medical System Products Portfolio
6.1.4.3. Strategic Moves (2013-14)
6.1.4.4. SCOT Analysis
6.1.5. BARCO NV
6.1.5.1. Overview
6.1.5.2. BARCO NV Products Portfolio
6.1.5.3. Strategic Moves (2013-14)
6.1.5.4. SCOT Analysis
6.1.6. Hitachi Medical Systems
6.1.6.1. Overview
6.1.6.2. Hitachi Medical System Products Portfolio
6.1.6.3. Strategic Moves (2013-14)
6.1.6.4. SCOT Analysis
6.2. 3 D Printing
6.2.1. Stryker
6.2.1.1. Overview
6.2.1.2. Strategic Moves (2013-14)
6.2.1.3. SCOT Analysis
6.2.2. 3D Systems Corporation
6.2.2.1. Overview
6.2.2.2. SCOT Analysis
6.2.3. Stratasys
6.2.3.1. Overview
6.2.3.2. SCOT Analysis
6.2.4. Arcam AB
6.2.4.1. Overview
6.2.4.2. SCOT Analysis
6.2.5. Envision TEC GMBH
6.2.5.1. Overview
6.2.5.2. SCOT Analysis
6.2.6. Materialise NV
6.2.6.1. Overview:
6.2.6.2. SCOT Analysis
CHAP 2. MARKET DETERMINANTS
2.1. Key Drivers
2.1.1. Better choice over conventional methods
2.1.2. Customized products
2.1.3. Research and Development
2.1.4. Innovative and advanced technologies
2.1.5. FDA nod to 3D innovative technologies
2.2. Restraints
2.2.1. High cost to individual patient
2.2.2. Lower Adoption rate
2.2.3. Regulations
2.3. Opportunity
2.3.1. Increase in joint replacement surgeries
2.3.2. Medical Tourism
2.3.3. Bio printing technology
2.4. Challenges
2.4.1. Transplantation of vital organs
2.4.2. High adoption rate of 3D technology is a challenge
2.4.3. Regulations are a hindrance for 3D technology
CHAP 3. 3D TECHNOLOGY IN HEALTHCARE - APPLICATION
3.1. 3D Printing
3.2. Implants
3.2.1. Example of use of 3D printing in implant
3.2.2. Advantages of 3D printing in healthcare
3.2.3. Dental Implants
3.2.4. Bio Engineering
3.2.5. Bio medical applications of 3D printing
3.3. 3D printing technologies
3.3.1. Electron beam melting
3.3.2. Laminated object manufacturing
3.3.3. Thermal Inkjet Printing
3.3.4. Selective Laser Sintering
3.3.5. Fused Deposition Modeling (FDM)
3.3.6. Photo polymerization
3.4. Raw material used for 3D printing in healthcare
3.4.1. Bio Ink
3.4.2. Ceramic
3.4.3. Polymers
3.4.4. Acrylonitrile Butadiene Styrene (ABS)
3.4.5. Polyactic Acid (PLA)
3.4.6. Metal
3.5. 3D Imaging
3.5.1. 3D mammography
3.5.2. 3D computed tomography
3.6. Virtual Reality
3.6.1. Use of virtual reality in therapy
CHAP 4. STRATEGIES TO STAY COMPETITIVE IN THE 3D TECHNOLOGY MARKET IN HEALTHCARE
4.1. Research and development give rise to innovative technologies
4.2. Stratasys partners with Worrell for new 3D printed medical devices
4.2.1. Organovo and Johnson & Johnson enter into partnership for 3D bio printing drug discovery research
4.2.2. Organovo enters into partnership with the Yale School of Medicine for 3D bioprinted tissue project
4.3. Acquisition gives upper hand over the competitors
4.3.1. Case Study
CHAP 5. GEOGRAPHICAL ANALYSIS
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. Regulations regarding medical devices in Europe
5.2.2. Prevalent diseases in Europe
5.2.3. United Kingdom (UK)
5.2.4. France
5.2.5. Germany
5.3. Asia Pacific (APAC)
5.3.1. China
5.3.1.1. Diseases prevalence in China
5.3.2. Japan
5.3.2.1. Regulations in Japan
5.3.3. India
CHAP 6. COMPANY PROFILING
6.1. 3 D Imaging
6.1.1. GE Healthcare
6.1.1.1. Overview
6.1.1.2. Strategic Moves
6.1.1.3. SCOT Analysis
6.1.2. Siemens Healthcare
6.1.2.1. Overview
6.1.2.2. Siemens Healthcare Products Portfolio
6.1.2.3. Strategic Moves (2013-14)
6.1.2.4. SCOT Analysis
6.1.3. Philips Healthcare
6.1.3.1. Overview
6.1.3.2. Phillips Healthcare Products Portfolio
6.1.3.3. Strategic Moves (2013-14)
6.1.3.4. SCOT Analysis
6.1.4. Toshiba Medical Systems
6.1.4.1. Overview
6.1.4.2. Toshiba Medical System Products Portfolio
6.1.4.3. Strategic Moves (2013-14)
6.1.4.4. SCOT Analysis
6.1.5. BARCO NV
6.1.5.1. Overview
6.1.5.2. BARCO NV Products Portfolio
6.1.5.3. Strategic Moves (2013-14)
6.1.5.4. SCOT Analysis
6.1.6. Hitachi Medical Systems
6.1.6.1. Overview
6.1.6.2. Hitachi Medical System Products Portfolio
6.1.6.3. Strategic Moves (2013-14)
6.1.6.4. SCOT Analysis
6.2. 3 D Printing
6.2.1. Stryker
6.2.1.1. Overview
6.2.1.2. Strategic Moves (2013-14)
6.2.1.3. SCOT Analysis
6.2.2. 3D Systems Corporation
6.2.2.1. Overview
6.2.2.2. SCOT Analysis
6.2.3. Stratasys
6.2.3.1. Overview
6.2.3.2. SCOT Analysis
6.2.4. Arcam AB
6.2.4.1. Overview
6.2.4.2. SCOT Analysis
6.2.5. Envision TEC GMBH
6.2.5.1. Overview
6.2.5.2. SCOT Analysis
6.2.6. Materialise NV
6.2.6.1. Overview:
6.2.6.2. SCOT Analysis
LIST OF TABLES
TABLE 1 GLOBAL 3D TECHNOLOGY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 2 COST OF IMPLANTATIONS, CONVENTIONAL METHOD IN 2011
TABLE 3 GLOBAL 3D PRINTING IN HEALTHCARE MARKET, 2013-2021 (IN $MILLION)
TABLE 4 GLOBAL 3D PRINTING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 5 PRICE COMPARISON BETWEEN FILAMENT OF ABS AND PLA (2013)
TABLE 6 GLOBAL 3D IMAGING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 7 GLOBAL 3D IMAGING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 8 GLOBAL 3D VIRTUAL REALITY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 9 GLOBAL 3D TECHNOLOGY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 10 NORTH AMERICAN 3D TECHNOLOGY MARKET 2014-2022 ($ MILLION)
TABLE 11 FACTSHEET (US HEALTH RECORDS 2011 AND 2012)
TABLE 12 EUROPEAN 3D TECHNOLOGY MARKET 2014-2022 ($ MILLION)
TABLE 13 PREVALENCE OF HEART DISEASES IN UK (2013)
TABLE 14 GE HEALTHCARE’S PRODUCT PORTFOLIO
TABLE 1 GLOBAL 3D TECHNOLOGY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 2 COST OF IMPLANTATIONS, CONVENTIONAL METHOD IN 2011
TABLE 3 GLOBAL 3D PRINTING IN HEALTHCARE MARKET, 2013-2021 (IN $MILLION)
TABLE 4 GLOBAL 3D PRINTING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 5 PRICE COMPARISON BETWEEN FILAMENT OF ABS AND PLA (2013)
TABLE 6 GLOBAL 3D IMAGING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 7 GLOBAL 3D IMAGING IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 8 GLOBAL 3D VIRTUAL REALITY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 9 GLOBAL 3D TECHNOLOGY IN HEALTHCARE MARKET 2014-2022 ($ MILLION)
TABLE 10 NORTH AMERICAN 3D TECHNOLOGY MARKET 2014-2022 ($ MILLION)
TABLE 11 FACTSHEET (US HEALTH RECORDS 2011 AND 2012)
TABLE 12 EUROPEAN 3D TECHNOLOGY MARKET 2014-2022 ($ MILLION)
TABLE 13 PREVALENCE OF HEART DISEASES IN UK (2013)
TABLE 14 GE HEALTHCARE’S PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1 Supply chain in 3 D healthcare 17
FIGURE 2 Global 3D printed implants market 2014-2022 ($ MILLION)
FIGURE 4 United States 3D technology Market 2014-2022 ($ MILLION)
FIGURE 5 Canada 3D technology Market 2014-2022 ($ MILLION)
FIGURE 6 UK 3D technology Market 2014-2022 ($ MILLION)
FIGURE 7 France 3D technology Market 2014-2022 ($ MILLION)
FIGURE 8 Germany 3D technology Market 2014-2022 ($ MILLION)
FIGURE 9 APAC 3D technology Market 2014-2022 ($ MILLION)
FIGURE 10 China 3D technology Market 2014-2022 ($ MILLION)
FIGURE 11 Japan 3D technology Market 2014-2022 ($ MILLION)
FIGURE 12 India 3D technology Market 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. GE Healthcare
2. Siemens Healthcare
3. Philips Healthcare
4. Toshiba Medical Systems
5. BARCO NV
6. Hitachi Medical Systems
7. Stryker
8. 3D Systems Corporation
9. Stratasys
10. Arcam AB
11. Envision TEC GMBH
12. Materialise NV
FIGURE 1 Supply chain in 3 D healthcare 17
FIGURE 2 Global 3D printed implants market 2014-2022 ($ MILLION)
FIGURE 4 United States 3D technology Market 2014-2022 ($ MILLION)
FIGURE 5 Canada 3D technology Market 2014-2022 ($ MILLION)
FIGURE 6 UK 3D technology Market 2014-2022 ($ MILLION)
FIGURE 7 France 3D technology Market 2014-2022 ($ MILLION)
FIGURE 8 Germany 3D technology Market 2014-2022 ($ MILLION)
FIGURE 9 APAC 3D technology Market 2014-2022 ($ MILLION)
FIGURE 10 China 3D technology Market 2014-2022 ($ MILLION)
FIGURE 11 Japan 3D technology Market 2014-2022 ($ MILLION)
FIGURE 12 India 3D technology Market 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. GE Healthcare
2. Siemens Healthcare
3. Philips Healthcare
4. Toshiba Medical Systems
5. BARCO NV
6. Hitachi Medical Systems
7. Stryker
8. 3D Systems Corporation
9. Stratasys
10. Arcam AB
11. Envision TEC GMBH
12. Materialise NV
